Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial - Concepedia

Concepedia

Publication | Closed Access

Activity of Exemestane in Metastatic Breast Cancer After Failure of Nonsteroidal Aromatase Inhibitors: A Phase II Trial

318

Citations

24

References

2000

Year

Per Eystein Lønning, Emilio Bajetta, Robin Murray, M. Tubiana-Hulin, Peter D. Eisenberg, E. Mickiewicz, Luigi Celio, Paula Pitt, Monica Mita, Neil K. Aaronson,

Journal of Clinical Oncology

Abstract

Exemestane 25 mg once daily seems to be an attractive alternative to chemotherapy for the treatment of patients with metastatic breast cancer after multiple hormonal therapies have failed.

References

	Year	Citations

Page 1